CTI BioPharma
CTIC
#5214
Rank
ยฃ0.92 B
Marketcap
ยฃ7.00
Share price
0.00%
Change (1 day)
23.08%
Change (1 year)

Operating Margin for CTI BioPharma (CTIC)

Operating Margin as of November 2024 (TTM): -172.37%

According to CTI BioPharma 's latest financial reports and stock price the company's current Operating Margin is -172.37%. At the end of 2019 the company had an Operating Margin of -1,150.97%.

Operating Margin history for CTI BioPharma from 2001 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
2019-1,150.97%995.63%
2018-105.05%-31.91%
2017-154.28%76.69%
2016-87.32%-88.1%
2015-733.86%381.56%
2014-152.39%25.79%
2013-121.15%
2010-23,434.17%-78.65%
2009-109,780.00%16146.65%
2008-675.71%-99.21%
2007-85,173.23%-30.48%
2006-122,511.25%43755.83%
2005-279.35%-46.13%
2004-518.53%4.75%
2003-494.99%-15.34%
2002-584.68%-56.33%
2001-1,338.76%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
14.38%-108.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.50%-91.59%๐Ÿ‡บ๐Ÿ‡ธ USA
6.71%-103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.50%-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
24.84%-114.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.93%-97.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
25.49%-114.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.